Renal Cell Carcinoma — Trials

Renal Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,621 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 375
Recruiting: 193
Ph III recruiting: 14
Growth YoY: +1.2%
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 39.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (276)

clinicaltrialsPublishedShowing 51–100 of 442 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06480565	A Phase 1/2 Trial of ADI-270 in ccRCC	active not recruiting	Phase 1 / Phase 2	60	Adicet TherapeuticsINDUSTRY	1	Sep 10, 2026	clinicaltrials
NCT01480154	Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer	active not recruiting	Phase 1	62	National Cancer Institute (NCI)NIH	1	Sep 9, 2026	clinicaltrials